Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516440 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

ALK-Abello AS - SWOT Analysis

MarketLine, Dec 2011, Pages: 24


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

ALK-Abello AS - SWOT Analysis company profile is the essential source for top-level company data and information. ALK-Abello AS - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

ALK-Abello (ALK) is a Denmark-based pharmaceutical group engaged in the development and marketing of allergy treatment. The group is focused on allergy vaccination. Its product portfolio includes allergy diagnosis products, such as skin prick tests, immunotherapy tablets and subcutaneous immunotherapy vaccination as well as products for allergy emergency treatment, such as auto-injectors containing adrenalin. ALK primarily operates in Europe. It is headquartered in Horsholm, Denmark, and employed 1,612 people as of December 31, 2010. The group recorded revenues of DKK2,140 million ($381.1 million-) during the financial year (FY) ended December 2010, an increase of 10.6% over FY2009. The operating profit of the group was DKK192 million ($34.2 million-) during FY2010, an increase of 9.7% over FY2009. The net profit was DKK128 million ($22.8 million-) in FY2010, an increase of 8.5% over FY2009. - Calculated using the constant conversion rate of DKK1 = $0.1781 for the financial year ended December 31, 2010.

Scope of the Report

- Provides all the crucial information on ALK-Abello AS required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting ALK-Abello AS in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of ALK-Abello AS
-Data is supplemented with details on ALK-Abello AS history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from ALK-Abello AS

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds